Search Index

- And face masks! No need to say they don’t work either. No matter the number of layers in the mask. Nothing is ever 100% efficient, and face masks are not exempt from this. Face masks help a lot by stopping you from inhaling COVID-19 particles in the air, indeed spread by people not wearing, or cannot wear, masks. Not just COVID-19 particles, Go back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Misconceptions about COVID-19 and its vaccine Last updated: 07/11/24 Published: 28/12/22 Three years into the pandemic, after huge losses in lives, livelihoods, and freedoms, misinformation about the coronavirus and now its vaccines, are still in circulation on the internet. It will take time to completely eradicate these misconstructions, but it is not impossible. I will begin discussing some myths and theories about the coronavirus itself, and then continue on to the vaccines science has developed to battle the virus. The misunderstandings are not listed in any order. Coronavirus The virus is called many different names: coronavirus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). The disease it causes is called COVID-19, or simply COVID. – Getting COVID is no big deal. It is just another flu. It is true yes that COVID-19 is only a mild condition for most people, however for those who are elderly and/ or clinically vulnerable it is anything but mild. Getting COVID-19 depends on the immune system, and if the immune system is already weakened, it is a big deal. As for the flu, it has been around for years mutating each time, but it is never less of a threat. – Only the elderly contract it. In most cases, it is the elderly who fall victim to the disease. But there are many factors at play; age is only one of them. Pre-existing health conditions regardless of age (for those clinically vulnerable), ethnicity, wealth, gender (does not factor that much), all determine who contracts it and how long it will take for someone to recover from the disease. – Children and teenagers are immune to it. Not necessarily true. For the better part of a year, children and younger adults seemed to evade COVID-19 but now more and more are falling ill to it. It is probably due to the emerging variants and how vulnerable children are. – Herd immunity is the way out. We do this by sacrificing said elderly to save the economy. It would have been the ideal solution to continue working and travelling while the virus ravages entire nations to protect the economy, but it would also have meant exposing society’s most vulnerable, namely the elderly, to the virus. Not a good solution to only protect one generation of society and not another. – Yes, because lockdowns don’t work. Lockdowns tend to have a rapid effect; they act to break the circuit of virus transmission up and down the country. They work. This is the reason why they last no more than one month or so when put in place. However, lockdown costs people’s freedoms and mental health so it should only be imposed when crucial. – But we need to work! How will we support ourselves? Very understandable. But if you suddenly contract COVID, you will not be able to work anyway. Many government initiatives have been started to support workers in the past year or so. - What is this 2m/ 6ft rule? No social contact whatsoever? The particles don’t even travel that far. The major way coronavirus travels is by droplets in the air between human contact. Not through surfaces (very little evidence supporting this), not by sharing needles, not by parasites and animals (vectors that bring the virus to humans). - And face masks! No need to say they don’t work either. No matter the number of layers in the mask. Nothing is ever 100% efficient, and face masks are not exempt from this. Face masks help a lot by stopping you from inhaling COVID-19 particles in the air, indeed spread by people not wearing, or cannot wear, masks. Not just COVID-19 particles, but any other harmful particles. You’re still able to take oxygen in and carbon dioxide out- these molecules are much smaller, 1-3 atoms big, so they can pass through the mask. Multiple layers of the mask offer more protection, however one is enough. - Antibiotics can be used to treat COVID-19. Antibiotics are anti-bacteria. Coronavirus is a virus- only antivirals will help. - Surely if bleach cleans and wipes out pathogens on surfaces and on just about anything else, it can do the same inside our bodies. Bleach is for surfaces only; they are not for consumption or administration as medicine. They will cause untold amount of damage inside the body. Bleach also turns things white. Whatever cleaning and wiping of pathogen need to be done, your immune system will do it. No need for bleach. - How does opening windows help prevent the spread of COVID-19? As mentioned before, COVID-19 respiratory particles travel by air. So opening windows and increasing the circulation of air, helps the particles to be blown away from you and the people with you and reduces the chance of becoming infected with the virus. Going outside for this reason helps (if not under lockdown or other restrictions). - How does fresh air help? As above. Vaccine – I think they will inject a microchip under the pretence of a vaccine and will track my every movement. There is no microchip. All the ingredients and chemicals used to produce the vaccines are available to view on the respective pharmaceutical website. None of the ingredients have any tracking potential. – Or they are just making money. Usually the government or state orders and buys the vaccines from the different companies. The expenses are on them. The rest of the population get the vaccine for free. - Vaccines hurt. Only a pinprick when the vaccine is being administered. After that only mild side effects and taking paracetamol or other painkillers will help. - And we are part of a big experiment. All the testing and experimenting was done during the three phases of clinical trials. The vaccines have been approved for (temporary) nationwide use. - Vaccines don’t work anyway. There is always a story in the news detailing the efficacies of the vaccines. They have an efficiency of 70-96% depending on the vaccine, and vaccine dose. Generally, the benefits of the vaccine far outweigh the risks that come from it. - Yes, because they cause shedding. Check the context and definition of this word. ‘Shedding’ here refers to the vaccine releasing or discharging its viral components onto others and infecting them. Once inside the body, the vaccine has no way to expel the viral contents.The only way the virus will shed its components is when the person is infected and sneezes, coughs, or causes the particles to travel in the air (i.e. when NOT vaccinated). - And, fertility issues. No biological mechanism or pathway has been discovered over the centuries that shows vaccines cause fertility issues. In fact, the reproductive system itself suppresses the immune system (not the other way round). - They will definitely cause issues if given to children. Vaccines were originally produced to provide protection to adults 18 years and older. Though there are vaccines that only children take as routine e.g. MMR (measles, mumps, rubella) and children don’t typically have any problems with them, COVID-19 vaccines aren’t among them. - Vaccines contain meat, and/ or made from animal products (and I am against this). As mentioned already, all the ingredients of the different vaccines can be found on the individual drug company websites. None of the vaccines contain meat, and if religion-conscious, scriptures advise the use of health agents even if they contain meat, to better your well-being. Anyway, the vaccine is used as medicine and not as an item for consumption. – You can pay to get a vaccine made from glucose sugar and water, and I believe it does the same thing as the official vaccine. Sugar solution is not a vaccine. It does not prevent against COVID-19. No trials have been conducted in favour of this. For a vaccine to be a vaccine, it is essential to have the actual weakened version or mRNA form of the virus. - Please take the time to read, watch, or listen to official government or health system information on coronavirus and vaccines. Millions if not billions have listened so far, be a part of this number. As with any public health guidance, education and spreading awareness are always key. Written by Manisha Halkhoree Related articles: COVID-19 glossary / Origins of COVID-19 / Digital disinformation / Fake science websites

Malaria is a vicious parasitic disease spread through the bite of the female Anopheles mosquito, with young children being its most prevalent victim. In 2021, there were over 600,000 reported deaths, giving us an insight into its Go Back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Could this new vaccine spell the end of malaria? Last updated: 20/01/25 Published: 01/02/23 Malaria is a vicious parasitic disease spread through the bite of the female Anopheles mosquito, with young children being its most prevalent victim. In 2021, there were over 600,000 reported deaths, giving us an insight into its alarming virulence. The obstacle in lessening malaria's disease burden is the challenge of creating a potent vaccine. The parasite utilises a tactic known as antigenic variation, where its extensive genetic diversity of antigens allows it to modulate its surface coat, allowing it to effectively evade the host immune system. However, unlike other variable malaria surface proteins, RH5, the protein required to invade red blood cells (RBC), does not vary and is therefore a promising target. Researchers at the University of Oxford have demonstrated various human antibodies that block the interaction between the RH5 malaria protein to host RBCs, providing hope for a new way to combat this deadly disease. The researchers have reported up to an 80% vaccine efficacy, surpassing the WHO's goal of developing a malaria vaccine with 75% efficacy. Therefore, this vaccine has the potential to be the world’s first highly effective malaria vaccine, and with adequate support in releasing this vaccine, we could be well on our way to seeing a world without child deaths from malaria. Written by Bisma Butt Related articles: Rare zoonotic diseases / mRNA vaccines

Page Not Found You can return to the homepage and try again. Go to Homepage

Getting treatment can prevent things from getting worse Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Depression in Children 10/07/25, 10:17 Last updated: Published: 17/06/23, 12:46 Getting treatment can prevent things from getting worse It's normal for kids to feel sad, act grouchy, or be in a bad mood at times. But when a sad or bad mood lasts for weeks or longer, and when there are other changes in a child's behavior, it might be depression. Therapy can help children who are going through sadness or depression. And there are things parents can do, too. Getting the right care can prevent things from getting worse and help a child feel better. Symptoms of depression Sad or bad mood. A child may seem sad, lonely, unhappy, or grouchy. It can last weeks or months. A child may cry more easily. They may have more tantrums than before. Being self-critical. Kids going through depression may complain a lot. They may say self-critical things like, "I can't do anything right." "I don't have any friends." "I can't do this." "It's too hard for me." Lack of energy and effort. Depression can drain a child's energy. They might put less effort into school than before. Even doing little tasks can feel like too much effort. Kids may seem tired, give up easily, or not try. Not enjoying things. Kids don't have as much fun with friends or enjoy playing like before. They may not feel like doing things they used to enjoy. Sleep and eating changes. Kids may not sleep well or seem tired even if they get enough sleep. Some may not feel like eating. Others may overeat. Aches and pains. Some children may have stomach aches or other pains. Some miss school days because of not feeling well, even though they aren't sick. Causes of depression Some common reasons include: - life events like someone dying - moving schools or other big changes - physical health problems - experiencing physical, sexual or psychological abuse or neglect - witnessing violence or a traumatic event - if you have an unstable family environment Intervention Three of the more common methods used in depression treatment include: - cognitive behavioral therapy - interpersonal therapy - psychodynamic therapy Written by Chhaya Dhedi Related articles: Childhood stunting in developing nations / What does depression do to your brain? / Brain of a bully / Anxiety / Postpartum depression in adolescent mothers Project Gallery

What is it and what does it do? Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The role of dopamine in the movement and the reward pathway 14/07/25, 15:01 Last updated: Published: 21/09/24, 15:59 What is it and what does it do? Dopamine is a neurotransmitter produced mainly in the ventral tegmental area (VTA) and the substantia nigra pars compacta (SNPC) in the brain, exhibiting both excitatory and inhibitory effects in different brain pathways. Dopamine is important in mediating the mesolimbic and nigrostriatal pathways for reward and movement, respectively. Therefore, damage to dopaminergic neurones affects dopamine levels in the brain and can consequently result in diseases associated with abnormal dopamine levels. Movement The role of dopamine is vital in modulating the initiation of movement through both the direct and indirect pathways of the basal ganglia ( Figure 1 ). In the direct pathway, dopamine produced from the SNPC binds to the D1 Gs-coupled receptors in the striatum resulting in the activation of the intracellular signalling cascade. Activation of these receptors results in increased intracellular cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) levels, which control the modulation of ion channels, including calcium channels for further depolarisation of the striatal cells. The excitation of the striatum results in GABAergic inhibition of the globus pallidus internal segment (GPI) and the substantia nigra pars reticulata (SNPR). Hence, this results in the disinhibition of the thalamus, allowing for excitatory glutamatergic transmission to the motor cortex for the facilitation of movement. The activation of the striatum via D1 receptor stimulation can be supported by a study conducted by Gerfen et al. 2012 in which they concluded that PKA activates calcium voltage-gated 1 L-type calcium channels, resulting in depolarisation of striatal cells, which causes the enablement of movement via the direct pathway. However, in the indirect pathway, dopamine binds to D2 Gi-coupled receptors with a higher affinity than D1 receptors, causing inhibition of these receptors and their intracellular signalling cascades. Consequently, there is decreased inhibition of potassium channels by the second messengers, resulting in hyperpolarisation due to potassium efflux from the striatal cells. As the striatum is inactivated, this reduces the overall inhibitory effect of the indirect pathway on the thalamus, allowing for movement. Therefore, dopamine is critical for the normal functioning of humans by allowing them to control their movements for survival, for example, by pushing a ball away when it is about to hit them. Reward pathway The mesolimbic dopaminergic pathway ( Figure 2 ) is the most recognised reward pathway in the brain. This pathway contains the VTA, located in the midbrain, the nucleus accumbens (NA) and the tuberculum olfactorium (TO), located in the basal forebrain. The lateral regions of the VTA are the most abundant in A10 dopaminergic neurones in comparison to other regions of the VTA. These A10 neurones are activated in association with reward anticipation, for example, after exercising. The medial VTA dopaminergic neurones project to the core and medial shell regions of the NA, and the lateral VTA project towards the lateral shell region of the NA (figure 3). Thus, increasing dopamine levels in the NA and inducing the processing of the reward. Moreover, dopaminergic inputs from the VTA to the TO allow the individual to develop an odour preference for a specific stimulus due to motivation-oriented behaviour. Hence, this could be a reason why the anticipation of eating one's favourite food by evoking the memory of its smell is associated with the feeling of reward. Experiments conducted by FitzGerald et al. 2014 support my points regarding the role of the TO in the mesolimbic pathway. In their study, mice were given a choice of two different odours to choose from. The team noted activation of c-Fos neurones in the forebrain, indicating neuronal activity in this region, which is involved in reward motivation behaviour. Hence, allowing them to support the importance of the TO in odour processing and reward behaviour in the mice when choosing a more pleasurable odour. Eventually, projections from the TO and NA converge at the ventral pallidum, where the enrichment of reward-related learning occurs. Therefore, dopamine is essential for the initiation of the reward pathway in ensuring the continuation of reward behaviour when exposed to a specific stimulus and for survival due to the association of reproduction with reward. Conclusion In conclusion, dopamine is essential for the initiation of movement and in the reward pathway for normal human functioning and survival. Studies into aldehyde-dehydrogenase 1 in the SNPC have found that it protects dopaminergic neurones against neurodegeneration. Further studies will aid in understanding the mechanisms by which this enzyme is regulated and the actions by which it protects dopaminergic neurones in the SNPC. Written by Maria Z Kahloon Related articles: The dopamine connection between the gut and the brain / Interplay of hormones and microbiome / Types of movement Project Gallery

The true cost Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Turkey Teeth 14/07/25, 15:06 Last updated: Published: 26/11/23, 10:57 The true cost Coined as 'Turkey teeth,' the rising trend of dental tourism has gained increasing popularity among the British population, largely influenced by social media. Many people are now traveling abroad for veneers, crowns, and implants, in the hope of achieving the perfect smile at a fraction of the cost in the UK. However, patients may be paying with their future oral health in the long run, as evidence emerges of botched procedures, with crucial steps missed and patients having long-lasting pain following their treatment. Many young people opt to visit cosmetic dentistry clinics in European countries to obtain veneers due to their cheaper costs compared to the UK dental fees, given that cosmetic dentistry is not covered under the subsidised NHS prices. However, it is becoming increasingly apparent that many consumers are in fact receiving full dental crowns without their knowledge, as opposed to veneers, thus sacrificing more of their natural tooth structure in the trade for a seemingly perfect smile. A critical difference between crowns and veneers is the amount of natural tooth structure removed to fit the prosthesis. Veneers are a much more minimally invasive fix, whereby 0.5mm of enamel is shaved away to allow a porcelain cover to fit to the surface of the tooth. Veneers are primarily used to conceal enamel discoloration, variations in shades, and natural tooth shapes. The minimally invasive procedure preserves tooth tissue and can even be potentially reversible in cases where there has been no preparation to the tooth. Crowns in the UK are vastly indicated for badly broken-down teeth and teeth deemed unrestorable. The preparation for a crown is far more invasive, with a significant amount of tooth structure irreversibly removed. This process sees teeth shaved down, with almost 2mm of the structure being irreversibly removed. Filing down teeth when they are otherwise perfectly clinically healthy can have dire consequences, and many patients returning to England have found themselves needing corrective work to rectify the procedures they underwent abroad. A study conducted by the Irish Dental Association revealed that 75% of those who travelled abroad for dental procedures required corrective work back home. The harsh reality of this treatment is that it can result in severe infections, long-lasting tooth pain, inflamed gums, exposed nerves, and heightened sensitivity. The destructive process of crown preparations in clinically healthy teeth increases the likelihood of exposing the tooth's pulp as more tooth tissue is removed, making the tooth more susceptible to infection. If the tooth's pulp becomes exposed, a costly and uncomfortable root canal procedure may be necessary. In the long term, these patients are more likely to lose the affected teeth altogether, as irreversible damage has occurred to the teeth. Another disadvantage of quick-fix dentistry abroad is the lack of follow-up appointments. In the UK, services such as occlusion checks are offered to ensure the bite is correct and that the veneers provide the desired result while lasting for an extended period. In contrast, dental procedures abroad are often expedited, sometimes limited to a single appointment as tourists return home swiftly to resume their daily lives. This can raise the risk of rushed procedures and a lack of follow-up to ensure the prosthetics' longevity. This has seen patients crowns falling off, and leaving their teeth exposed. In a typical UK dental clinic, the process involves an initial assessment, a dental health check, trial designs, and finally, the fitting of new veneers. Teeth are meticulously assessed for potential issues, including periodontal disease, and bite evaluations are performed to ensure that the prosthetics do not interfere with the occlusion. This comprehensive approach differs significantly from the one-appointment dentistry often observed abroad. Love Island's Jack Finham underwent the procedure and documented his experience across social media to thousands of followers. He later went on to reveal that in hindsight, he would not have chosen the procedure has he known its intricacies. Influencers are slowly turning to reveal the true costs of fast dentistry abroad, and it can only be hoped that consumers become better informed on the processes performed abroad, and are more well informed before making an irreversible decision for their teeth. In conclusion, it is imperative for consumers to be well-informed when considering dental procedures, especially when faced with the allure of cheaper veneers, or rather crowns abroad. While the cost savings may initially seem enticing, the potential risks associated with overseas treatments, including inadequate follow-ups, irreversible damage to natural tooth structure, and a lack of comprehensive assessments, should not be overlooked. Opting for dentistry in the UK provides a safer and more comprehensive approach, with qualified professionals who prioritize patients' oral health and long-term well-being. While affordability is a significant consideration, the adage "you get what you pay for" holds true in the realm of dental care. Informed decision-making and prioritizing one's health should always take precedence when seeking dental treatments, ensuring not only a beautiful smile but also lasting oral health. Written by Isha Parmar Project Gallery

What my role entails Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Exploring My Role as a Clinical Computer Scientist in the NHS 17/04/25, 10:23 Last updated: Published: 06/05/24, 13:03 What my role entails When we think about career choices, we’re often presented with singular choices. Clinical Scientific Computing is a field that combines healthcare and computing. Despite it being relatively unknown, it is an important cog in the healthcare machine. When I applied for the Scientific Training Program in 2021, the specialism I applied for (Clinical Scientific Computing) had one of the lowest application rates out of approximately 27 specialisms. Awareness of this area has now improved, both thanks to better advertisement and exponential advancements in technology and healthcare. According to the NHS, there are now 26.8 thousand full-time equivalent healthcare scientists in England's NHS. As a clinical computer scientist, one's expertise can be applied in diverse settings, including medical physics laboratories and clinical engineering departments. My role in radiotherapy involves overseeing the technical aspects of clinical workflows, ensuring the seamless integration of technology in patient care. Training is a crucial part of being a proficient computer scientist. Especially with the growth of scientific fields in the NHS, there's always an influx of juniors and trainees, and that in turn, warrants the need for excellent trainers. A clinical scientist is someone who is proficient in their craft and able to explain complex concepts in layman's terms. As Einstein famously said: If you can't explain it to a 6-year-old, you can't understand it yourself. Although I am still technically a trainee, I am expected to partake in the training of the more junior trainees in my schedule. On a typical day, this may be as simple as explaining a program and demonstrating its application, or I may dismantle a PC and go through each component, one by one. At the core of clinical science is research. You won't go a day without working on at least one project and sometimes these may not even be your own. Collaboration with others is a huge part of the job. Every scientist has a different way of thinking about a problem, and this is exactly what keeps the wheels spinning in a scientific department. There are numerous times when I seek the help of others and vice versa. It is difficult to talk about 'typical' projects because they are often so varied in scientific computing, but it is likely that you will find yourself working on a variety of programming tasks. Having clinical know-how is crucial when working on projects in this field, and that aspect is exactly what separates the average computer scientist from the clinical computer scientist. A project I am currently working on involves radiation dose calculations, which naturally involves understanding the biological effects of radiation on the human body. This isn't a typical software development project so having a passion for healthcare is absolutely necessary. The unpredictability of technology means that troubleshooting is a constant aspect of our work. If something goes wrong in the department (which it often does), it is our responsibility as technical experts to quickly but effectively diagnose and fix the problems. The clinical workflow is highly sensitive in healthcare especially the cancer pathway where every minute counts. If a radiographer is unable to access patient records or there is an error with a planning system, this can have detrimental effects on the quality of patient care. Addressing errors, like those in treatment planning systems, necessitates a meticulous approach to diagnosis, often leading us from error code troubleshooting to on-site interventions. For example, I may be required to physically attend a treatment planning room and resolve an issue with the PC. This narrative offers a glimpse into the day-to-day life of a clinical computer scientist in the NHS, highlighting the critical blend of technical skill, continuous learning, and the profound impact on patient care. Through this lens, we can hopefully appreciate the essential role of clinical scientific computing in advancing healthcare, marked by innovation, collaboration, and a commitment to improving patient outcomes. This narrative offers a glimpse into the day-to-day life of a clinical computer scientist in the NHS, highlighting the critical blend of technical skill, continuous learning, and the profound impact on patient care. Through this lens, we can hopefully appreciate the essential role of clinical scientific computing in advancing healthcare, marked by innovation, collaboration, and a commitment to improving patient outcomes. For more information on this specialism . Written by Jaspreet Mann Related articles: Virtual reality in healthcare / Imposter syndrome in STEM Project Gallery

The closest planet to the Sun Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Exploring the solar system: Mercury 09/07/25, 14:08 Last updated: Published: 27/06/23, 15:46 The closest planet to the Sun Mercury, the closest planet to the Sun, holds a significant place in our understanding of the solar system and serves as our first stepping stone in the exploration of the cosmos. Its intriguing history dates back to ancient times when it was studied and recorded by the Babylonians in their celestial charts. Around 350 BC the ancient Greeks, recognized that the celestial body known as the evening and morning star was, in fact, a single entity. Impressed by its swift movement, they named it Hermes, after the swift messenger of their mythology. As time passed, the Roman Empire adopted the Greek discovery and bestowed upon it the name of their equivalent messenger god, Mercury, a name by which the planet is known today. This ancient recognition of Mercury's uniqueness paved the way for our continued exploration and study of this fascinating planet. Mercury's evolution As Mercury formed from the primordial cloud of gas and dust known as the solar nebula, it went through a process called accretion. Small particles collided and gradually merged together, forming larger bodies called planetesimals. Over time, these planetesimals grew in size through further collisions and gravitational attraction, eventually forming the protoplanet that would become Mercury. However, the proximity to the Sun presented unique challenges for Mercury's formation. The Sun emitted intense heat and powerful solar winds that swept away much of the planet's initial atmosphere and surface materials. This process, known as solar stripping or solar ablation, left behind a relatively thin and tenuous atmosphere compared to other planets in the solar system. The intense heat also played a crucial role in shaping Mercury's surface. The planet's surface rocks melted and differentiated, with denser materials sinking towards the core while lighter materials rose to the surface. This process created a large iron-rich core, accounting for about 70% of the planet's radius. Mercury's lack of significant geological activity, such as plate tectonics, has allowed its surface to retain ancient features and provide insights into the early history of our solar system. The planet's surface is dominated by impact craters, much like the Moon. These craters are the result of countless collisions with asteroids and comets over billions of years. The largest and most prominent impact feature on Mercury is the Caloris Basin, a vast impact crater approximately 1,525 kilometres in diameter. The impact of such large celestial bodies created shockwaves and volcanic activity, leaving behind a scarred and rugged terrain. Scientists estimate that the period known as the Late Heavy Bombardment, which occurred around 3.8 to 4.1 billion years ago, was particularly tumultuous for Mercury. During this time, the inner planets of our solar system experienced a high frequency of cosmic collisions. These impacts not only shaped Mercury's surface but also influenced the evolution of other rocky planets like Earth and Mars. Studying Mercury's geology and surface features provides valuable insights into the early stages of planetary formation and the impact history of our solar system. Exploration history Our understanding of Mercury has greatly benefited from a series of pioneering missions that ventured close to the planet and provided valuable insights into its characteristics. Let's delve into the details of these key exploratory endeavours: Mariner 10 (1974-1975): Launched by NASA, Mariner 10 was the first spacecraft to conduct a close-up exploration of Mercury. It embarked on a series of three flybys, passing by the planet in 1974 and 1975. Mariner 10 captured images of approximately 45% of Mercury's surface, revealing its heavily cratered terrain. The spacecraft's observations provided crucial information about the planet's rotation period, which was found to be approximately 59 Earth days. Mariner 10 also discovered that Mercury possessed a magnetic field, albeit weaker than Earth's. MESSENGER (2004-2015): The MESSENGER mission, short for Mercury Surface, Space Environment, Geochemistry, and Ranging, was launched by NASA in 2004. It became the first spacecraft to enter into orbit around Mercury in 2011, marking a significant milestone in the exploration of the planet. Over the course of more than four years, MESSENGER conducted an extensive study of Mercury's surface and environment. It captured detailed images of previously unseen regions, revealing the planet's diverse geological features, including vast volcanic plains and cliffs. MESSENGER's data also indicated the presence of water ice in permanently shadowed craters near Mercury's poles, surprising scientists. Furthermore, the mission discovered that Mercury possessed a global magnetic field, challenging previous assumptions about the planet's magnetism. MESSENGER's observations greatly expanded our knowledge of Mercury's geology, composition, and magnetic properties. BepiColombo (2018-Present): The BepiColombo mission, a joint endeavour between the European Space Agency (ESA) and the Japan Aerospace Exploration Agency (JAXA), aims to further enhance our understanding of Mercury. The mission consists of two separate orbiters: the Mercury Planetary Orbiter (MPO) developed by ESA and the Mercury Magnetospheric Orbiter (MMO) developed by JAXA. Launched in 2018, BepiColombo is currently on its journey to Mercury, with an expected arrival in 2025. Once there, the mission will study various aspects of the planet, including its magnetic field, interior structure, and surface composition. The comprehensive data collected by BepiColombo's orbiters will contribute significantly to our knowledge of Mercury and help answer remaining questions about its formation and evolution. These missions have played pivotal roles in advancing our understanding of Mercury. They have provided unprecedented insights into the planet's surface features, composition, magnetic field, and geological history. As exploration efforts continue, we can anticipate further revelations and a deeper understanding of this intriguing world. Future exploration While significant advancements have been made in understanding Mercury, there is still much more to learn. Scientists hope to explore areas of the planet that have not yet been observed up close, such as the north pole and regions where water ice may be present. They also aim to study Mercury's thin atmosphere, which consists of atoms blasted off the surface by the solar wind. Moreover, the advancement of technology may lead to the development of innovative missions to Mercury. Concepts such as landing missions and even manned exploration have been proposed, although the challenges associated with the planet's extreme environment and proximity to the Sun make such endeavours highly demanding. Nevertheless, the quest to unravel Mercury's mysteries continues, driven by the desire to deepen our knowledge of planetary formation, evolution, and the unique conditions that shaped this enigmatic world. Exploring the uncharted areas of Mercury, particularly the north pole, holds great scientific potential. The presence of water ice in permanently shadowed regions has been suggested by previous observations, and investigating these areas up close could provide valuable insights into the planet's volatile history and the potential for water resources. Additionally, studying Mercury's thin atmosphere is of significant interest. Comprised mostly of atoms blasted off the surface by the intense solar wind, understanding the composition and dynamics of this atmosphere could shed light on the processes that shape Mercury's exosphere. In conclusion, while significant progress has been made in unravelling the mysteries of Mercury, there is still much to explore and discover. Scientists aspire to investigate untouched regions, study the planet's thin atmosphere, and employ innovative mission concepts. The future may hold ambitious missions, including landing missions and potentially even manned exploration. As our knowledge and capabilities expand, Mercury continues to beckon us with its fascinating secrets, urging us to push the boundaries of exploration and expand our understanding of the wonders of the solar system. And with that we finish our journey into the history and exploration of Mercury and will move to Venus in the next article. Written by Zari Syed Related articles: Fuel for the colonisation of Mars / Nuclear fusion Project Gallery

Why chirality is important in developing drugs Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Chirality in drugs 04/02/25, 15:50 Last updated: Published: 06/06/23, 16:53 Why chirality is important in developing drugs Nearly 90% of the drugs currently on the market are racemates, which are composed of an equimolar mixture of two enantiomers, and approximately half of all drugs are chiral compounds. Chirality is the quality of an item that prevents it from superimposing on its mirror counterpart, similar to left and right hands. Chirality, a generic characteristic of "handedness,"plays a significant role in the creation of several pharmaceutical drugs. It's interesting to note that 20 of the 35 drugs the Food and Drug Administration (FDA) authorised in 2020 are chiral drugs. For example, Ibuprofen, a chiral 2-aryl propionic acid derivative, is a common over-the-counter analgesic, antipyretic, and anti-inflammatory medication. However, Ibuprofen and other medications from similar families can have side effects and risks related to their usage. Drugs of the chiral class have the drawback that only one of the two enantiomers may be active, while the other may be ineffective or have some negative effects. The inactive enantiomer can occasionally interact with the active enantiomer, lowering its potency or producing undesirable side effects. Additionally, Ibuprofen and other members of the chiral family of pharmaceuticals can interact with other drugs, including over-the-counter and prescription ones. To guarantee that only the active enantiomer is present in chiral-class medications, it is crucial for pharmaceutical companies to closely monitor their production and distribution processes. Lessening the toxicity or adverse effects linked to the inactive enantiomer, medical chemistry has recently seen an increase in the use of enantiomerically pure drugs. In any instance, the choice of whether to utilise a single enantiomer or a combination of enantiomers of a certain medicine should be based on clinical trial results and clinical competence. In addition to requests to determine and control the enantiomeric purity of the enantiomers from a racemic mixture, the use of single enantiomer drugs may result in simpler and more selective pharmacological profiles, improved therapeutic indices, simpler pharmacokinetics, and fewer drug interactions. Although, there have been instances where the wrong enantiomer results in unintended side effects, many medications are still used today as racemates with their associated side effects; this issue is probably brought on by both the difficulty of the chiral separation technique and the high cost of production. In conclusion, Ibuprofen and other medications in the chiral family, including those used to treat pain and inflammation, can be useful, but they also include a number of dangers and adverse effects. It's critical to follow a doctor's instructions when using these medications and to be aware of any possible interactions, allergic reactions, and other hazards. To maintain the security and efficacy of medicines in the chiral class, pharma producers also have a duty to closely monitor their creation and distribution. Written by Navnidhi Sharma Project Gallery

Integrins are desirable to target cancer Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Biochemistry of cancer: integrins, the desirable targets 20/03/25, 12:01 Last updated: Published: 24/05/23, 08:39 Integrins are desirable to target cancer Every year, eight million people worldwide pass away from cancer, and this number is expected to rise. Cancer can damage a wide range of organs in people of various ages. It is quite honest to say that Cancer is the most common and severe problem in clinical medicine. Cancer's fundamental problems shed light on the biochemical and genetic processes underlying the unchecked expansion of cancer cells. The extracellular matrix (ECM)'s biochemical and biomechanical properties affect how sensitive cells are. Cell health depends on different reactions, such as proliferation, apoptosis, migration, and differentiation. The tumour microenvironment also largely influences cancer metastasis, medication resistance, and recurrence. Transmembrane glycoproteins called integrins mediate connections between cells and the ECM and connect it to the cytoskeleton. They relay the information from the ECM through downstream signalling pathways and can hence control the properties of the cell. Mammals have so far been found to contain 24 different integrin heterodimers, formed by combining 18 α- and 8 β-subunits. A cell's ability to bind to specific ECM elements depends on the pattern of integrin expression, which also affects how a cell recognises and reacts to its surroundings. These same integrin-mediated pathways are used by tumour cells in the context of cancer to boost invasiveness and oncogenic survival as well as to create a host milieu that supports tumour development and metastatic dissemination ( Figure 1 ). Hence, Integrins are interesting targets for cancer therapy due to their role in tumour progression, and several integrin antagonists, including antibodies and synthetic peptides, have been successfully used in clinics for cancer therapy. Unligated integrins may have a detrimental effect on tumour survival. They are generally unligated in adherent cells, which leads to the cleavage of caspase 8, which in turn causes tumour cells to undergo apoptosis through a process known as integrin-mediated death (IMD) ( Figure 2 ). Integrins' precise chemical signals and the mechanical environment of the ECM control how cancer cells behave. A key role is also played by the ECM's physicochemical environment. Chemically altered substrate surfaces have been used to study this interaction, but topology and functionality control are still difficult to achieve. Modifying a cell's local chemical environment does offer a viable method for selectively controlling the behaviour of cancer cells. Together, targeted external cue presentation has the potential to enhance existing intracellular cancer therapy approaches. When combined with other targeted therapies (tyrosine kinase inhibitors, anti-growth factor antibodies) for anticancer treatment, integrin inhibition may be used as a potential target for drug development. However, it needs to be thoroughly evaluated in the pre-clinical phase, possibly taking into account all of the plausible escape mechanisms by which tumour cells can develop. Written by Navnidhi Sharma Related articles: Why whales don't get cancer / Breast cancer and asbestos / MOFs in cancer drug delivery / Anti-cancer metal compounds REFERENCES Hamidi, H., Pietilä, M., & Ivaska, J. (2016). The complexity of integrins in cancer and new scopes for therapeutic targeting. British Journal of Cancer, 115(9), 1017–1023. https://doi.org/10.1038/bjc.2016.312 Jacob, M., Varghese, J., Murray, R. K., & Weil, P. A. (2016). Cancer: An Overview (V. W. Rodwell, D. A. Bender, K. M. Botham, P. J. Kennelly, & P. A. Weil, Eds.). Access Medicine; McGraw-Hill Education. https://accessmedicine.mhmedical.com/content.aspx?bookid=1366§ionid=73247495 Li, M., Wang, Y., Li, M., Wu, X., Setrerrahmane, S., & Xu, H. (2021). Integrins as attractive targets for cancer therapeutics. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2021.01.004 Yoshii, T., Geng, Y., Peyton, S., Mercurio, A. M., & Rotello, V. M. (2016). Biochemical and biomechanical drivers of cancer cell metastasis, drug response and nanomedicine. Drug Discovery Today, 21(9), 1489–1494. https://doi.org/10.1016/j.drudis.2016.05.011 Zhao, H., F. Patrick Ross, & Teitelbaum, S. L. (2005). Unoccupied αvβ3Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal. Molecular Endocrinology, 19(3), 771–780. https://doi.org/10.1210/me.2004-0161 Project Gallery